#1 Clinical Trials Search in Europe

Ceftriaxone Sodium

Ceftriaxone Sodium, a broad-spectrum antibiotic, is being extensively studied in clinical trials for its efficacy in treating various medical conditions. These trials aim to evaluate its effectiveness, safety, and potential new applications in areas such as surgical site infections, intra-abdominal infections, urinary tract infections, and even neuropsychiatric disorders like bipolar depression. The research spans different patient populations and compares Ceftriaxone Sodium to other treatments, providing valuable insights into its optimal use in modern medicine.

Table of Contents

What is Ceftriaxone Sodium?

Ceftriaxone Sodium is a powerful antibiotic medication that belongs to a class of drugs called cephalosporins[1]. It is also known by other names such as Rocephin[2]. This medication is used to treat a wide range of bacterial infections and is often considered a broad-spectrum antibiotic, meaning it can fight against many different types of bacteria[3].

What Conditions Does Ceftriaxone Sodium Treat?

Ceftriaxone Sodium is used to treat various bacterial infections, including:

  • Intra-abdominal infections: These are infections that occur within the abdomen, such as appendicitis or peritonitis[1].
  • Urinary tract infections (UTIs): Ceftriaxone can be effective against complicated UTIs[4].
  • Surgical site infections: It is used to prevent infections that may occur after surgery, particularly in colorectal procedures[2].
  • Gonorrhea: A sexually transmitted infection caused by the bacteria Neisseria gonorrhoeae[5].
  • Sepsis: A life-threatening condition that occurs when the body’s response to infection causes widespread inflammation[6].
  • Complicated appendicitis: An advanced form of appendicitis where the infection has spread beyond the appendix[7].

How is Ceftriaxone Sodium Administered?

Ceftriaxone Sodium is typically administered in the following ways:

  • Intravenous (IV) infusion: The most common method, where the drug is given directly into a vein over a period of time[4].
  • Intramuscular (IM) injection: In some cases, it may be injected into a muscle[4].
  • Single dose: For certain conditions like gonorrhea, a single dose may be sufficient[5].
  • Multiple doses: For more severe infections, multiple doses over several days may be necessary[1].

The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient’s age and overall health condition.

Effectiveness of Ceftriaxone Sodium

Ceftriaxone Sodium has shown high effectiveness in treating various bacterial infections. For example:

  • In treating complicated intra-abdominal infections, it has demonstrated similar efficacy to other antibiotic combinations[1].
  • For preventing surgical site infections in colorectal surgery, it has been found to be non-inferior (not worse than) to standard antibiotic combinations[2].
  • In the treatment of gonorrhea, it has shown high rates of bacterial eradication[5].

Ceftriaxone in Combination with Other Drugs

Ceftriaxone Sodium is often used in combination with other antibiotics to enhance its effectiveness or broaden its spectrum of activity. Some common combinations include:

  • Ceftriaxone + Metronidazole: This combination is frequently used for intra-abdominal infections[1].
  • Ceftriaxone + Sulbactam: This combination is being studied for the treatment of gonorrhea[5].
  • Ceftriaxone + Mecobalamin: This combination is being researched for its potential in treating liver injury associated with sepsis[6].

Potential Side Effects and Safety Considerations

While Ceftriaxone Sodium is generally well-tolerated, it can cause side effects in some patients. Common side effects may include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Rash

More serious side effects, although rare, can include severe allergic reactions, especially in patients with a history of penicillin allergy[7]. It’s important to inform your healthcare provider about any allergies or previous adverse reactions to antibiotics before starting treatment with Ceftriaxone Sodium.

Ongoing Research and Future Prospects

Researchers continue to explore new applications and combinations for Ceftriaxone Sodium. Some interesting areas of ongoing research include:

  • Treatment of bipolar depression: A study is investigating the potential use of intravenous ceftriaxone as an augmentation therapy for patients with bipolar disorder who have not responded to conventional treatments[8].
  • Prevention of surgical site infections: Research is being conducted on the use of intra-peritoneal ceftriaxone instillation during surgery to prevent infections in pediatric patients with complicated appendicitis[7].
  • Combination therapy for sepsis-related liver injury: A study is exploring the combination of ceftriaxone with mecobalamin for treating liver dysfunction associated with sepsis[6].

These ongoing studies may lead to new applications and improved treatment strategies using Ceftriaxone Sodium in the future.

Aspect Details
Main Conditions Studied Surgical site infections, intra-abdominal infections, complicated urinary tract infections, bipolar depression
Administration Methods Primarily intravenous (IV), sometimes as a single dose, other times as multiple doses over several days
Comparison Treatments Tigecycline, ertapenem, metronidazole, placebo (saline solution)
Patient Populations Adults, pediatric patients (in some studies), patients undergoing surgery, patients with specific infections
Primary Outcomes Measured Infection rates, clinical response, microbiological response, changes in depression rating scales
Novel Applications Use in bipolar depression, local antibiotic instillation in appendicitis
Study Designs Randomized controlled trials, open-label studies, double-blind studies

FAQ

  • What is Ceftriaxone Sodium used for in clinical trials? Ceftriaxone Sodium is being studied in clinical trials for various purposes, including prevention of surgical site infections, treatment of intra-abdominal infections, management of complicated urinary tract infections, and even as a potential therapy for bipolar depression.
  • How is Ceftriaxone Sodium typically administered in these trials? In most trials, Ceftriaxone Sodium is administered intravenously (IV). The dosage and frequency can vary depending on the specific condition being treated and the study protocol. For example, some trials use a single dose before surgery, while others involve daily doses over several days.
  • Are there any side effects associated with Ceftriaxone Sodium in clinical trials? While specific side effects are not detailed in the provided information, all medications can have potential side effects. In clinical trials, researchers closely monitor participants for any adverse events. It's important to note that the safety profile of Ceftriaxone Sodium is well-established from its long-term use in clinical practice.
  • How does Ceftriaxone Sodium compare to other antibiotics in these trials? Several trials compare Ceftriaxone Sodium to other antibiotics or antibiotic combinations. For instance, it's compared to tigecycline in intra-abdominal infections and to ertapenem in colorectal surgery prophylaxis. These comparisons help determine the relative efficacy and safety of Ceftriaxone Sodium in different clinical scenarios.
  • Why is Ceftriaxone Sodium being studied for bipolar depression? The use of Ceftriaxone Sodium in bipolar depression is an innovative approach based on its potential to modulate glutamatergic neurotransmission. This study explores whether the antibiotic could have beneficial effects on mood disorders, representing a novel application beyond its traditional use as an antibiotic.

Ongoing Clinical Trials on Ceftriaxone Sodium

  • Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark

  • Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway Sweden

  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium The Netherlands

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France The Netherlands Sweden

Glossary

  • Ceftriaxone Sodium: A broad-spectrum antibiotic used to treat various bacterial infections. It belongs to the cephalosporin class of antibiotics and is typically administered intravenously or intramuscularly.
  • Surgical Site Infection (SSI): An infection that occurs after surgery in the part of the body where the surgery took place. SSIs can sometimes be superficial infections involving the skin only, or more serious infections involving tissues under the skin, organs, or implanted material.
  • Intra-abdominal Infection: An infection that occurs within the abdomen. These can be serious and may involve organs such as the appendix, gallbladder, or intestines.
  • Complicated Urinary Tract Infection: A urinary tract infection that has additional factors making it more difficult to treat, such as structural or functional abnormalities of the urinary tract, or the presence of catheterization.
  • Bipolar Depression: The depressive phase of bipolar disorder, a mental health condition characterized by extreme mood swings including emotional highs (mania or hypomania) and lows (depression).
  • Prophylaxis: Preventive treatment or measures taken to prevent a disease or condition from occurring.
  • Randomized Controlled Trial: A type of scientific experiment where participants are randomly allocated to receive either the treatment under investigation or a placebo/standard treatment. This helps to reduce bias and provide the most reliable evidence on the effectiveness of an intervention.
  • Efficacy: The ability of a drug or medical treatment to produce a desired effect under ideal circumstances, such as in a clinical trial.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure, regardless of whether it is considered related to the medical treatment or procedure.

References

  1. https://clinicaltrials.gov/study/NCT00195351
  2. https://clinicaltrials.gov/study/NCT01254344
  3. https://clinicaltrials.gov/study/NCT04975945
  4. https://clinicaltrials.gov/study/NCT01014013
  5. https://clinicaltrials.gov/study/NCT04202068
  6. https://clinicaltrials.gov/study/NCT06220929
  7. https://clinicaltrials.gov/study/NCT05470517
  8. https://clinicaltrials.gov/study/NCT00566111